Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003044705 | SCV003349040 | pathogenic | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2022-05-05 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with COL12A1-related conditions. For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Gln1428*) in the COL12A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL12A1 are known to be pathogenic (PMID: 24334604, 28973083). This variant is not present in population databases (gnomAD no frequency). |